Sterling, founded in 1976, is a specialised company exclusively dedicated to developing and manufacturing steroidal APIs. Its capabilities range from large scale, highly automated manufacturing to smaller-scale specialist production requiring greater hands on attention. The manufacturing facilities have state-of-the-art control systems and its environment is highly contained. Sterling API facilities have an excellent compliance track record with a strong FDA and AIFA (Italian Health Authority) audit history.
